Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQB2922 Combined With Chemotherapy in First-Line RAS/BRAF Wild-Type Unresectable Metastatic Colorectal Cancer
NCT07844187Phase 2Not yet recruiting
- Sponsor
- Chia Tai Tianqing
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of tqb2922 in colorectal cancer (CRC), sponsored by Chia Tai Tianqing. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tqb2922
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07844187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07844187.